v3.24.0.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash Flows from Operating Activities:      
Net loss attributable to common stockholders $ (802,142) $ (1,377,987) $ (1,523,195)
Adjustments to reconcile net loss to net cash flows used in operating activities:      
Depreciation and amortization 201,920 169,252 121,138
Non-cash interest expense, net 386 870 2,109
Stock-based compensation expense 398,463 578,799 683,293
Loss (gain) on remeasurement of warrant liabilities 57,543 (29,396) (30,065)
Loss (gain) from equity method investment 719 2,895 (2,718)
Loss (gain) on marketable equity securities and other financial assets, net 75 (10,999) (11,311)
Deferred income taxes 5,849 (73,407) (15,509)
Other expenses, net 554 (7,268) 0
Change in operating assets and liabilities, net of effect of acquisitions:      
Receivables reserved for users (141,687) (105,320) (21,700)
Accounts receivables 3,558 2,506 (1,787)
Prepaid expenses and other current assets 2,451 (26,217) (10,078)
Deposits and other non-current assets (19,355) (4,921) (6,458)
Operating leases, net 6,558 1,304 (1,059)
Accounts payable and accrued expenses 103,593 95,269 167,927
Liabilities to users 165,725 152,985 210,932
Long-term income tax liability 2,952 (9,267) 13,227
Other long-term liabilities 11,087 15,383 5,746
Net cash flows used in operating activities (1,751) (625,519) (419,508)
Cash Flows from Investing Activities:      
Purchases of property and equipment (20,902) (32,402) (15,925)
Cash paid for internally developed software costs (80,378) (64,030) (46,542)
Acquisition of gaming licenses (12,105) (7,213) (35,809)
Proceeds from (purchase of) marketable equity securities and other financial assets 24,425 0 (25,000)
Cash paid for acquisitions, net of cash acquired 0 (96,507) (64,970)
Other investing activities, net (1,400) (8,614) (6,776)
Net cash flows used in investing activities (90,360) (208,766) (195,022)
Cash Flow from Financing Activities:      
Proceeds from issuance of convertible notes, net 0 0 1,248,025
Purchase of capped call options 0 0 (123,970)
Proceeds from exercise of warrants 288 44 693
Purchase of treasury stock (80,049) (25,519) (17,830)
Proceeds from exercise of stock options 16,540 8,743 31,479
Other financing activities 0 0 416
Net cash flows (used in) provided by financing activities (63,221) (16,732) 1,138,813
Effect of foreign exchange rates on cash and cash equivalents, restricted cash, and cash reserved for users 0 0 583
Net (decrease) increase in cash and cash equivalents, restricted cash, and cash reserved for users (155,332) (851,017) 524,866
Cash and cash equivalents, restricted cash, and cash reserved for users at the beginning of period 1,778,825 2,629,842 2,104,976
Cash and cash equivalents, restricted cash, and cash reserved for users at the end of period 1,623,493 1,778,825 2,629,842
Disclosure of cash and cash equivalents, restricted cash, and cash reserved for users      
Cash and cash equivalents 1,270,503 1,309,172 2,152,892
Restricted cash 11,700 0 0
Cash reserved for users 341,290 469,653 476,950
Cash and cash equivalents, restricted cash, and cash reserved for users at the end of period 1,623,493 1,778,825 2,629,842
Supplemental Disclosure of Noncash Investing and Financing Activities:      
Investing activities included in accounts payable and accrued expenses 569 9,155 (3,758)
Equity consideration issued for acquisitions 0 460,128 33,149
Decrease in warrant liabilities from cashless exercise of warrants 4,654 0 0
Supplemental Disclosure of Cash Activities:      
(Decrease) increase in cash reserved for users (128,363) (7,297) 189,232
Cash paid for interest 0 0 0
Cash paid for income taxes, net of refunds $ 8,341 $ 10,366 $ 5,632